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Introduction
Antiretroviral therapy (ART) decreases HIV-1 viremia and
AIDS-associated mortality. Despite this, HIV infected
patients are unable to clear virus during treatment inter-
ruption due to insufficient cytotoxic T cell (CTL) activity
against the autologous reservoir. It is unclear if naïve T
cells from patients on ART can respond to immunothera-
pies that induce CTL specific for their own, unique virus.
Unfortunately, late-evolving virus and the ART reservoir
contain escape epitope variants that confer a lack of CTL
control. We hypothesize that a dendritic cell (DC)-based
immunotherapy during ART can induce CTL capable of
eliminating the autologous reservoir, despite their failure
to do so during natural infection.
Materials and methods
We use a naïve T cell flow cytometry panel to evaluate
changes in the naive CD4+:CD8+ T cell ratio before sero-
conversion, during untreated infection, and after ART in
an HIV infected subject. We then use this panel to isolate
naive CD4+ and CD8+ T cells from this patient during
ART and from HIV negative donors. These purified naive
T cells are then used in an in vitro model of dendritic cell
(DC) vaccination at their in vivo ratios to induce primary
IFNg-producing CTL against autologous HIV-1 Gag, Env,
and Nef peptide antigens derived from ART.
Results
Although partial immune reconstitution occurs during
ART, we observed a disproportionate recovery in the
naïve CD4+:CD8+ T cell ratio compared to pre-infec-
tion. Despite this, we show that naïve CD4+ and CD8+
T cells from ART, when primed at their skewed in vivo
ratio against late-acquired, “escape” epitope variants, dif-
ferentiate into IFNg-producing CTL comparable to
those induced in pre-seroconversion T cells. Addition-
ally, we show that primary CTL responses induced dur-
ing ART are comparable to those observed in HIV
negative donors. Figure 1.
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Conclusion
These data indicate that, despite a disproportionate
recovery in the naive CD4+:CD8+ T cell ratio, DC vac-
cination of naïve T cells from ART can induce CTL spe-
cific for autologous “escape” HIV-1 variants, and that
these naive T cells can respond to primary vaccination
at a level similar to pre-infection. These data support
the use of DC immunotherapies in HIV infected
patients on ART.
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